Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CARM1 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
mRNA | PNMT | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
mRNA | ILF2 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
mRNA | TFE3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
mRNA | RP11-111M22.2 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
mRNA | NUTF2 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
mRNA | SPINK5 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
mRNA | POLA1 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
mRNA | SCN3A | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
mRNA | VAMP2 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |